Table 5.
Past medical history and procedural data grouped by vital status at 30 days.
| Survival at 30 days | p value | ||
|---|---|---|---|
| Alive (N = 10548) | Deceased (N = 891) | ||
| Past medical history | |||
| Previous MI N (%) | 1679 (16.1) | 163 (18.7) | 0.045 |
| Previous CABG n (%) | 553 (5.3) | 80 (9.2) | <0.001 |
| Previous PCI N (%) | 1311 (12.6) | 83 (9.5) | 0.008 |
| Diabetes N (%) | 2020 (19.9) | 198 (23.5) | 0.014 |
| Hypertension N (%) | 4347 (41.2) | 344 (38.6) | 0.129 |
| Total cholesterol | 5.34 ± 16.2 | 5.1 ± 1.5 | 0.916 |
| Asthma/COPD N (%) | 682 (6.6) | 88 (10.4) | <0.001 |
| CVA N (%) | 85 (0.8) | 12 (1.3) | 0.091 |
| Creatinine | 87.5 ± 1.36 | 131.3 ± 5.49 | <0.001 |
| Smoking status (%) | |||
| Never smoked | 43.4 | 48.5 | <0.001 |
| Ex-smoker | 27.4 | 31.2 | |
| Current smoker | 29.1 | 20.3 | |
| Procedural data | |||
| LMS disease N (%) | 301 (4.4) | 93 (20) | <0.001 |
| Epicardial disease N (%) | |||
| Single-vessel | 4226 (63.2) | 195 (44.6) | <0.001 |
| Two-vessel | 1632 (24.4) | 138 (31.6) | |
| Three-vessel | 626 (9.4) | 95 (21.7) | |
| Inotropes N (%) | 72 (0.7) | 57 (6.4) | <0.001 |
| IABP n(%) | 213 (2) | 96 (10.8) | <0.001 |
| Impella∗N (%) | 7 (0.1) | 9 (1) | <0.001 |
| ECMO∗N (%) | 8 (0.1) | 20 (2.2) | <0.001 |
| TIMI flow after PCI (%) | |||
| 0 | 2.1 | 7.7 | <0.001 |
| I | 0.9 | 4.1 | |
| II | 3.7 | 12.3 | |
| III | 93.2 | 75.9 | |
| Access site (%) | |||
| Radial | 63.9 | 35.9 | <0.001 |
| Femoral | 36.1 | 64.1 | |
∗ECMO and Impella entry in database 2018 onwards, MI: myocardial infarction, CABG: coronary artery bypass surgery, PCI: percutaneous coronary intervention, COPD, chronic obstructive pulmonary disease, CVA: cerebrovascular accident, LMS: left main stem disease, IABP: intra-aortic balloon pump, ECMO: extra corporeal membrane oxygenation, and TIMI: thrombolysis in myocardial infarction.